Overview


According to FutureWise analysis the market for adme toxicology testing is expected to register a CAGR of 11.7% from 2023-2031.

Absorption, Distribution, Metabolism, and Elimination is abbreviated as ADME. It is an important concept that explains a chemical or drug's potential effect on a living system within the context of cellular biology and biochemistry.

Pharmaceutical compounds undergo a series of essential processes known as ADME, which stands for Absorption, Distribution, Metabolism, and Excretion. These compounds are typically bound to the surface. They must be absorbed into the bloodstream, often with the help of mucous surfaces, such as the digestive tract (intestinal absorption), before being taken up by the intended cells. Certain factors such as solubility, gastric emptying time, chemical stability in the stomach, and the ability to permeate the intestinal wall affect a drug's absorption, impacting its bioavailability.

If a drug is absorbed poorly when taken orally, alternative administration routes such as intravenous or inhalation is employed. Distribution involves the transport of the compound through the bloodstream to its site of action, often into different organs and tissues. Metabolism refers to the breakdown of compounds in the body, primarily in the liver, where enzymes convert the parent compound into metabolites. These metabolites may be pharmacologically active or inactive, impacting the drug's effects. Finally, excretion removes the drug and its metabolites from the body, typically through the kidneys (urine), faeces, or even the lungs in the case of certain substances. Considering these processes and potential toxicity is crucial in drug development and administration. The chosen route of administration plays a pivotal role in determining these ADME characteristics.

FutureWise Market Research has published a report that provides an insightful analysis of ADME Toxicology Testing Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts’ projects that ADME Toxicology Testing Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Thermo Fisher Scientific Inc.
  • Promega Corporation
  • Agilent Technologies, Inc.
  • Albany Molecular Research Inc. (AMRI)
  • Dassault Systèmes
  • Beckman Coulter, Inc.
  • Charles River Laboratories.
  • Covance Inc.
  • Eurofins Scientific
  • General Electric
  • Merck KGaA
  • Miltenyi Biotec
  • Bio-Rad Laboratories, Inc.
  • Cyprotex Limited
  • BioIVT LLC.

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Technology

  • Cell Culture
  • High Throughput
  • Molecular Imaging
  • OMICS Technology

By Application

  • Systemic Toxicity
  • Renal Toxicity
  • Hepatotoxicity
  • Neurotoxicity
  • Other Toxicities

By Method

  • Cellular Assay
  • Biochemical Assay
  • In-Silica
  • Ex-vivo

By Product Type

  • Instruments
  • Software Solutions
  • Assays Systems
  • Reagents
  • Others

By Test

  • In-Vivo
  • In-Vitro

By End-Users

  • Cosmetics and Household Products
  • Pharmaceutical Industry
  • Animal Industry
  • Food Industry
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the ADME Toxicology Testing Market By Technology, By Application, By Method, By Product Type, By Test, By End-Users and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   ADME Toxicology Testing Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of ADME Toxicology Testing Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   ADME Toxicology Testing Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   ADME Toxicology Testing Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Cell Culture
        2. High Throughput
        3. Molecular Imaging
        4. OMICS Technology

  • 8.   ADME Toxicology Testing Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Systemic Toxicity
        2. Renal Toxicity
        3. Hepatotoxicity
        4. Neurotoxicity
        5. Other Toxicities

  • 9.   ADME Toxicology Testing Market, By Method Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Cellular Assay
        2. Biochemical Assay
        3. In-Silica
        4. Ex-vivo

  • 10.   ADME Toxicology Testing Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Instruments
        2. Software Solutions
        3. Assays Systems
        4. Reagents
        5. Others

  • 11.   ADME Toxicology Testing Market, By Test Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. In-Vivo
        2. In-Vitro

  • 12.   ADME Toxicology Testing Market, By End-Users Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Cosmetics and Household Products
        2. Pharmaceutical Industry
        3. Animal Industry
        4. Food Industry
        5. Others

  • 13.   North America ADME Toxicology Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 14.   Latin America ADME Toxicology Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 15.   Europe ADME Toxicology Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 16.   Asia Pacific ADME Toxicology Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 17.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 18.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 19.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Thermo Fisher Scientific Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Promega Corporation
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Agilent Technologies, Inc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Albany Molecular Research Inc. (AMRI)
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Dassault Systèmes
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Beckman Coulter, Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Charles River Laboratories.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Covance Inc.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Eurofins Scientific
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. General Electric
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Merck KGaA
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Miltenyi Biotec
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Bio-Rad Laboratories, Inc.
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Cyprotex Limited
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. BioIVT LLC.
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview

  • 20.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 21.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients